BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 34388057)

  • 21. Thrombotic microangiopathy with concomitant GI aGVHD after allogeneic hematopoietic stem cell transplantation: Risk factors and outcome.
    Zhang XH; Liu X; Wang QM; He Y; Zhu XL; Zhang JM; Han W; Chen H; Chen YH; Wang FR; Wang JZ; Zhang YY; Mo XD; Chen Y; Wang Y; Fu HX; Chang YJ; Xu LP; Liu KY; Huang XJ
    Eur J Haematol; 2018 Feb; 100(2):171-181. PubMed ID: 29114931
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New approaches in the diagnosis, pathophysiology, and treatment of pediatric hematopoietic stem cell transplantation-associated thrombotic microangiopathy.
    Jodele S; Dandoy CE; Myers KC; El-Bietar J; Nelson A; Wallace G; Laskin BL
    Transfus Apher Sci; 2016 Apr; 54(2):181-90. PubMed ID: 27156964
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Short Course of Eculizumab May Be Effective in Dialysis-Dependent Transplantation-Associated Thrombotic Microangiopathy After Hematopoietic Stem Cell Transplantation: A Case Report.
    Jarmoliński T; Rosa M; Puziewicz-Zmonarska A; Kałwak K
    Transplant Proc; 2020 Oct; 52(8):2544-2547. PubMed ID: 32917392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interplay of Inflammation and Endothelial Dysfunction in Bone Marrow Transplantation: Focus on Hepatic Veno-Occlusive Disease.
    Vion AC; Rautou PE; Durand F; Boulanger CM; Valla DC
    Semin Thromb Hemost; 2015 Sep; 41(6):629-43. PubMed ID: 26305238
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A new paradigm: Diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury.
    Jodele S; Laskin BL; Dandoy CE; Myers KC; El-Bietar J; Davies SM; Goebel J; Dixon BP
    Blood Rev; 2015 May; 29(3):191-204. PubMed ID: 25483393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatic veno-occlusive disease accompanied by thrombotic microangiopathy developed during treatment of juvenile dermatomyositis and macrophage activation syndrome: A case report.
    Mouri M; Kanamori T; Tanaka E; Hiratoko K; Okubo M; Inoue M; Morio T; Shimizu M; Nishino I; Okiyama N; Mori M
    Mod Rheumatol Case Rep; 2023 Jun; 7(2):404-409. PubMed ID: 36416547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renal dysfunction following bone marrow transplantation.
    Kemmner S; Verbeek M; Heemann U
    J Nephrol; 2017 Apr; 30(2):201-209. PubMed ID: 27589851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thrombosis in stem cell transplantation.
    Kansu E
    Hematology; 2012 Apr; 17 Suppl 1():S159-62. PubMed ID: 22507809
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating dsDNA, endothelial injury, and complement activation in thrombotic microangiopathy and GVHD.
    Gloude NJ; Khandelwal P; Luebbering N; Lounder DT; Jodele S; Alder MN; Lane A; Wilkey A; Lake KE; Litts B; Davies SM
    Blood; 2017 Sep; 130(10):1259-1266. PubMed ID: 28705839
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal Complications after Hematopoietic Stem Cell Transplantation: Role of Graft-Versus-Host Disease in Renal Thrombotic Microangiopathy.
    Mii A; Shimizu A; Yamaguchi H; Tsuruoka S
    J Nippon Med Sch; 2020 Mar; 87(1):7-12. PubMed ID: 31776318
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation.
    Dignan FL; Wynn RF; Hadzic N; Karani J; Quaglia A; Pagliuca A; Veys P; Potter MN; ;
    Br J Haematol; 2013 Nov; 163(4):444-57. PubMed ID: 24102514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transplant-associated thrombotic microangiopathy: elucidating prevention strategies and identifying high-risk patients.
    Jodele S; Sabulski A
    Expert Rev Hematol; 2021 Aug; 14(8):751-763. PubMed ID: 34301169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Allogeneic hematopoietic stem cell transplantation associated thrombotic microangiopathy: 16 cases report and literature review].
    Han W; Han Y; Chen J; Ma X; Chen F; Wu XJ; Qi JQ; Qiu HY; Sun AN; Wu DP
    Zhonghua Xue Ye Xue Za Zhi; 2016 Aug; 37(8):666-70. PubMed ID: 27587247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of Eculizumab in Patients With Allogeneic Stem Cell Transplant-Associated Thrombotic Microangiopathy: A Study From the SFGM-TC.
    de Fontbrune FS; Galambrun C; Sirvent A; Huynh A; Faguer S; Nguyen S; Bay JO; Neven B; Moussi J; Simon L; Xhaard A; Resche-Riggon M; O'Meara A; Fremeaux-Bacchi V; Veyradier A; Socié G; Coppo P; de Latour RP
    Transplantation; 2015 Sep; 99(9):1953-9. PubMed ID: 25651309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Management of transplant-associated thrombotic microangiopathy].
    Ikezoe T
    Rinsho Ketsueki; 2018; 59(10):2307-2314. PubMed ID: 30305540
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Small vessels, big trouble in the kidneys and beyond: hematopoietic stem cell transplantation-associated thrombotic microangiopathy.
    Laskin BL; Goebel J; Davies SM; Jodele S
    Blood; 2011 Aug; 118(6):1452-62. PubMed ID: 21596850
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of Eculizumab in Thrombotic Microangiopathy Associated with Hematopoietic Stem Cell Transplantation.
    Demircioglu S; Dogan A; Demir C
    J Coll Physicians Surg Pak; 2021 Nov; 31(11):1359-1361. PubMed ID: 34689499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) and Growth Differentiation Factor-15 (GDF-15) Levels Are Significantly Associated with Endothelial Injury Indices in Adult Allogeneic Hematopoietic Cell Transplantation Recipients.
    Gavriilaki E; Bousiou Z; Batsis I; Vardi A; Mallouri D; Koravou EE; Konstantinidou G; Spyridis N; Karavalakis G; Noli F; Patriarcheas V; Masmanidou M; Touloumenidou T; Papalexandri A; Poziopoulos C; Yannaki E; Sakellari I; Politou M; Papassotiriou I
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203404
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors of Transplant-Associated Thrombotic Microangiopathy in Patients With Overlap or Chronic Graft-vs-Host-Disease.
    Gavriilaki E; Sakellari I; Chatzikonstantinou T; Bousiou Z; Mallouri D; Masmanidou M; Vardi A; Koravou EE; Kika F; Touloumenidou T; Papalexandri A; Yannaki E; Batsis I; Anagnostopoulos A
    Transplant Proc; 2021 Sep; 53(7):2261-2266. PubMed ID: 34417030
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reeling in complement in transplant-associated thrombotic microangiopathy: You're going to need a bigger boat.
    Jodele S; Sabulski A
    Am J Hematol; 2023 May; 98 Suppl 4():S57-S73. PubMed ID: 36746623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.